RE:Canopy growth target price is (12 & 25 C$) incl sell ratings Explained much better here, why you will see the shift eventually in Tilray SP and out performing CGC/Weed.
Titan Tilray is #1.
All analysts know it, we know it, institutional investors know it and the consumer knows it.
It's only a matter of time until we take our rightful spot at the top of Canadian LP's for not only the Titan it is, but the SP it should be rightfully at, #1...
How many times has TILRAY been EBITDA POSTIVE? Yeah, that's right :-)
I'm sure we will take a hit on CGC earnings, but only temporary. No blood here, Just a few scratches for being involved in the match.
Cheers,
V
Humanist wrote: PART OF AN ARTICLE ABOUT CANOPY , I FOUND V INTERESTING
The Canadian LP we selected to better explain this trend is Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC), which was the largest cannabis company in the world a few years ago (based on market capitalization). Below we highlighted changes in price target on Canopy Growth since November and believe our readers should be aware of this.
- February 7th – Eight Capital cut its price target by approx. 42% (from C$12 to C$7)
- February 2nd – CIBC cut its price target by 25% (from C$12 to C$9)
- January 6th – AGP cut its price target by approx. 38% (from C$18 to C$11)
- Dec 22nd – Bank of America cut its price target by approx. 47% (from C$18 to C$11)
- Dec 19th – Piper Sandler cut its price target by approx. 39% (from $11 to $7)
- November 9th – MKM cut its price target by 45% (from C$51 to C$28)
- November 8th – Canaccord Genuity cut its price target by 52% (from C$25 to C$12)
- November 8th – Cowen cut its price target by 51% (from C$33 to C$16)
Over the course of this timeframe, three broker-dealers changed its rating on Canopy Growth to Sell and we find this to be significant. The three firms were Bank of America, Canaccord Genuity, and Piper Sandler.
FOR THE FULL ARTICLE
https://technical420.com/cannabis-article/canopy-growth-just-continues-to-get-beat-up-by-the-streets-top-broker-dealers/#